NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,269,000 | -21.0% | 4,256,526 | 0.0% | 0.20% | -19.0% |
| Q2 2020 | $2,871,000 | +17.3% | 4,256,526 | 0.0% | 0.25% | -9.4% |
| Q1 2020 | $2,448,000 | -56.4% | 4,256,526 | 0.0% | 0.28% | -70.5% |
| Q4 2019 | $5,619,000 | -34.0% | 4,256,526 | 0.0% | 0.94% | -64.6% |
| Q3 2019 | $8,513,000 | -17.7% | 4,256,526 | 0.0% | 2.66% | +0.5% |
| Q2 2019 | $10,343,000 | -0.4% | 4,256,526 | 0.0% | 2.65% | +6.0% |
| Q1 2019 | $10,386,000 | +77.3% | 4,256,526 | +6.1% | 2.50% | +65.5% |
| Q4 2018 | $5,858,000 | -49.0% | 4,012,374 | -5.7% | 1.51% | -28.2% |
| Q3 2018 | $11,493,000 | – | 4,256,526 | – | 2.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,074,190 | $33,368,000 | 6.74% |
| Novo Holdings A/S | 2,903,800 | $23,782,000 | 3.10% |
| PURA VIDA INVESTMENTS, LLC | 425,000 | $3,481,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $3,276,000 | 0.59% |
| Monashee Investment Management LLC | 188,000 | $1,540,000 | 0.58% |
| Orbimed Advisors | 3,919,600 | $32,102,000 | 0.31% |
| FT Options LLC | 20,000 | $164,000 | 0.25% |
| Rock Springs Capital Management LP | 625,000 | $5,119,000 | 0.24% |
| Rubric Capital Management LP | 300,000 | $2,457,000 | 0.22% |
| Ghost Tree Capital, LLC | 120,000 | $983,000 | 0.21% |